Physician profile
Steven Jay Bowman
NPI 1487867610
$914,671.25
in general payments reported to CMS, 2019-2025
5 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277K · 2020: $164K · 2021: $327K · 2022: $42K · 2023: $37K · 2024: $37K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $104K · Food and Beverage: $498 · Gift: $46.86 · Entertainment: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $104,453.36 |
| Food and Beverage | $497.93 |
| Gift | $46.86 |
| Entertainment | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona Orthodontics INC | $607,438.90 | 2019-2021 | |
| Hu-Friedy Mfg. Co., LLC | $306,477.40 | 2019-2025 | Hu-Friedy Mfg. Co., LLC |
| American Orthodontics Corporation | $563.62 | 2022-2025 | Master Series, Radiance, Empower-Ceramic |
| Align Technology, INC. | $173.22 | 2021-2023 | Invisalign First - Comprehensive, Itero Element 5d Plus Lite, Invisalign Touch Up |
| Gc America INC. | $18.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.